Related Experiment Video
Updated: May 23, 2026

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
Published on: March 17, 2014
Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea
Mehran Ghoreishi1, Cristián Vera Kellet, Jan P Dutz
1Department of Dermatology & Skin Science and Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract:
Morphea is an autoimmune sclerotic skin disease of unknown pathogenesis. As type 1 interferons (IFN) have been implicated in the pathogenesis of systemic sclerosis, we proposed that type 1 IFN promote localized inflammation and fibrosis in morphea. To investigate the expression of the type 1 IFN-inducible protein myxovirus A (MxA) and the presence of plasmacytoid dendritic cells (pDC) in lesions of morphea, lesional skin of 10 patients with morphea was examined by immunohistochemistry for the presence of the type 1 IFN-inducible protein, myxovirus A (MxA), and the pDC markers, CD123 and BDCA-2, and was compared with lesional skin of cutaneous lupus erythematosus, lichen planus and keloid. Lesional and non-lesional morphea skin was compared. MxA was expressed in the epidermis as well as the reticular dermis and subcutis in morphea. pDCs were abundant around vessels and between fibrous bundles. Non-lesional biopsies demonstrated little or no expression of MxA and pDC markers. Keloid showed minimal expression of MxA and pDC markers. We demonstrate the expression of type 1 IFN-related protein MxA and plasmacytoid DCs in lesional but not in non-lesional biopsies of morphea. These findings suggest a potential role for type 1 interferons in the pathogenesis of morphea.
Insights
Type 1 interferons (IFN) may drive morphea, an autoimmune skin disease. Researchers found elevated MxA protein and plasmacytoid dendritic cells (pDCs) in morphea lesions, suggesting a role for type 1 IFN in disease pathogenesis.
Area of Science:
- Immunodermatology
- Autoimmune skin diseases
- Fibrotic disorders
Background:
- Morphea is an autoimmune sclerotic skin disease with unknown causes.
- Type 1 interferons (IFN) are implicated in systemic sclerosis pathogenesis.
- A potential role for type 1 IFN in morphea's inflammation and fibrosis is proposed.
Purpose of the Study:
- To investigate the expression of type 1 IFN-inducible protein MxA and plasmacytoid dendritic cells (pDCs) in morphea lesions.
- To compare these markers in morphea with other skin conditions like cutaneous lupus erythematosus, lichen planus, and keloid.
- To compare lesional and non-lesional morphea skin.
Main Methods:
- Immunohistochemistry was used to examine skin biopsies from 10 morphea patients.
- Expression of MxA, CD123, and BDCA-2 (pDC markers) was assessed.
- Comparisons were made between lesional and non-lesional morphea skin, and with other skin conditions.
Main Results:
- MxA was expressed in the epidermis, reticular dermis, and subcutis of morphea lesions.
- Plasmacytoid dendritic cells (pDCs) were abundant in morphea lesions, particularly around vessels and fibrous bundles.
- Non-lesional morphea skin and keloid samples showed minimal to no expression of MxA and pDC markers.
Conclusions:
- The study demonstrates the presence of type 1 IFN-related protein MxA and pDCs in lesional, but not non-lesional, morphea skin.
- These findings suggest a potential role for type 1 interferons in the pathogenesis of morphea.
- Further research into type 1 IFN pathways may offer new therapeutic targets for morphea.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Inflammation: Introduction
